Trial intelligence / Profile preview

Azathioprine vs Methotrexate with Adalimumab in Crohn's Disease

NCT05040464Phase 3Recruiting

Sponsor
CHU Amiens-Picardie
Start
Aug 2021
Primary completion
Aug 2026
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of azathioprine, methotrexate in Crohn's disease, sponsored by CHU Amiens-Picardie. Started Aug 2021; status: recruiting.

02

Drugs

azathioprinemethotrexate
03

Conditions

Crohn's disease

Beyond the preview

Go deeper on NCT05040464.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05040464.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call